Wolverine Trading, LLC Eye Point Pharmaceuticals, Inc. Call Options Transaction History

Wolverine Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$7.58 - $10.54 $3,032 - $4,216	400 Added 2.74%	15,000 $119,000
Q2 2024 Aug 14, 2024	BUY	$8.16 - $22.89 $119,136 - $334,194	14,600 New	14,600 $127,000
Q1 2023 May 15, 2023	SELL	$2.28 - $5.04 $12,995 - $28,728	-5,700 Reduced 33.14%	11,500 $37,000
Q4 2022 Feb 14, 2023	BUY	$2.37 - $7.2 $40,764 - $123,840	17,200 New	17,200 $60,000
Q1 2022 May 16, 2022	SELL	$8.67 - $14.11 $191,607 - $311,831	-22,100 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.18 - $18.4 $119,106 - $215,279	11,700 Added 112.5%	22,100 $281,000
Q1 2021 May 14, 2021	SELL	$8.89 - $14.92 $24,892 - $41,776	-2,800 Reduced 21.21%	10,400 $101,000
Q4 2020 Feb 12, 2021	BUY	$3.7 - $6.58 $48,840 - $86,856	13,200 New	13,200 $78,000

150

58M

177K

263K

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $305M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.